Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (2035)	5/27/2003 10:36:35 AM
From: Ken W	Read Replies (2) \| Respond to of 23958

Sergio INSM: stockcharts.com[m,a]daolyyay[pb50!b200][vc60][iUb14!Lp14,3,3]&pref=G Good for two bucks, first resistance. The recent relisting is a definite positive as well as upcoming Phase III testing to be announced. BVF Partners (a biotech value fund) has been a constant buyer of the stock. I also noticed that they are heavy into CVAS (one of our other picks) Insiders have been buyers also. Downside is minimal at 1.50 at a horizontal support line..could become a simple channel trader (I love that!) or a break over 2.00 takes it to 2.50ish. Ken

To: Sergio H who wrote (2035)	5/29/2003 1:31:34 PM
From: Crossy	Read Replies (2) \| Respond to of 23958

Sergio, I conceded on SMAN - the life insurance industry is in the crapper now and capgains and dividend taxcuts are only going to make this area even more attractive. I'm going to remove it from my portfolio and wanted to inform you that I do not value this company the way I would have weeks ago - another reason are changed external market conditions. Pure value is not enough. You have to adjust to that. I don'T ask you to remove it from the Yeehaw portfolio but I would not object to your doing it either all I do is removing my "coverage" rgrds CROSSY